SATB2 and metastatic malignant neoplasm in the lymph nodes: Lack of SATB2 expression has been reported as an adverse prognostic factor in sporadic CRCs, even in those harboring MMR-d, while it was associated with lymph node metastases in colitis-associated CRC [33,38,39,40].